BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22659417)

  • 21. Induction of matrix metalloproteinases by Epstein-Barr virus latent membrane protein 1 isolated from nasopharyngeal carcinoma.
    Lee DC; Chua DT; Wei WI; Sham JS; Lau AS
    Biomed Pharmacother; 2007 Oct; 61(9):520-6. PubMed ID: 17913445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis induced by atRA in MEPM cells is mediated through activation of caspase and RAR.
    Yu Z; Han J; Lin J; Xiao Y; Zhang X; Li Y
    Toxicol Sci; 2006 Feb; 89(2):504-9. PubMed ID: 16291826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
    Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
    J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus-encoded latent membrane protein 1 promotes stress-induced apoptosis upstream of caspase-2-dependent mitochondrial perturbation.
    Zhang X; Uthaisang W; Hu L; Ernberg IT; Fadeel B
    Int J Cancer; 2005 Jan; 113(3):397-405. PubMed ID: 15455353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of apoptosis by rewiring the signal transduction of Epstein-Barr virus oncoprotein LMP1 toward caspase activation.
    Hatzivassiliou EG; Tsichritzis T; Mosialos G
    J Virol; 2005 Apr; 79(8):5215-9. PubMed ID: 15795305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP).
    Ruemmele FM; Dionne S; Qureshi I; Sarma DS; Levy E; Seidman EG
    Cell Death Differ; 1999 Aug; 6(8):729-35. PubMed ID: 10467346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1].
    Chen Y; Chen XY
    Ai Zheng; 2002 May; 21(5):498-503. PubMed ID: 12452040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.
    Kim KR; Yoshizaki T; Miyamori H; Hasegawa K; Horikawa T; Furukawa M; Harada S; Seiki M; Sato H
    Oncogene; 2000 Mar; 19(14):1764-71. PubMed ID: 10777210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of Epstein-Barr virus latent membrane protein 1 on metastasis of human nasopharyngeal carcinoma cell lines].
    Ou XB; Chen XY; Wu MH; Luo WR
    Ai Zheng; 2008 Aug; 27(8):803-8. PubMed ID: 18710612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D; Srivatanakul P; Karalak A; Ishida T
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of inhibition of EBV-encoded latent membrane protein-1 by small interfering RNA on EBV-positive nasopharyngeal carcinoma cell growth.
    Li G; Li XP; Peng Y; Liu X; Li XH
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):241-6. PubMed ID: 15041532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation and nuclear translocation of STAT3 regulated by the Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma.
    Liu YP; Tan YN; Wang ZL; Zeng L; Lu ZX; Li LL; Luo W; Tang M; Cao Y
    Int J Mol Med; 2008 Feb; 21(2):153-62. PubMed ID: 18204781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Latent membrane protein 1 of Epstein-Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression.
    Wu ZZ; Chow KP; Kuo TC; Chang YS; Chao CC
    Biochem Pharmacol; 2011 Dec; 82(12):1860-72. PubMed ID: 21945668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Epstein-Barr virus latent membrane protein 1 (LMP1) enhances TNF alpha-induced apoptosis of intestine 407 epithelial cells: the role of LMP1 C-terminal activation regions 1 and 2.
    Kawanishi M
    Virology; 2000 May; 270(2):258-66. PubMed ID: 10792984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
    Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
    Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma.
    Hu L; Troyanovsky B; Zhang X; Trivedi P; Ernberg I; Klein G
    Cancer Res; 2000 Oct; 60(19):5589-93. PubMed ID: 11034108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological properties of TW01 cells expressing latent membrane protein-1 gene of EBV-derived from nasopharyngeal carcinoma cells at different stages of malignancy.
    Tan EL; Sam CK
    Exp Oncol; 2007 Sep; 29(3):166-74. PubMed ID: 18004239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.